NBI 42902
Latest Information Update: 28 Feb 2011
At a glance
- Originator Neurocrine Biosciences
- Class Pyrimidinones; Small molecules
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia; Breast cancer; Endometriosis; Prostate cancer; Uterine leiomyoma